Search filters

List of works by Chitra Hosing

A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center

scientific article published on 3 July 2017

A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients

scientific article published on 01 November 2020

A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma

scientific article published on 5 April 2018

A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease

scientific article

A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid

scientific article

A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results

scientific article published on 9 May 2017

A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma

scientific article

A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin’s lymphomas ⬇️

scientific article published on April 14, 2010

Activated autologous dendritic cells injected intratumorally are able to overcome local and systemic immune suppression imposed by the tumor and its microenvironment.

scientific article published on 6 November 2014

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation

scientific article published on 01 March 2004

Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States

scientific article

Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience

scientific article

Age is a prognostic factor for the overall survival of multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation

scientific article published on 28 November 2019

Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma

scientific article published on 4 April 2017

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan

scientific article

Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation

scientific article

Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution

scientific article published on 28 September 2015

Allotransplants for patients 65 years or older with high-risk acute myeloid leukemia

article

An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection

scientific article

Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial

scientific article

Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation

scientific article published on 16 May 2011

Augmentation of blood dendritic cells by extracorporeal photopheresis in patients with leukemic cutaneous T-cell lymphoma and graft-versus-host disease

scientific article published on 21 March 2013

Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients

scientific article published on 27 March 2015

Autologous Stem Cell Transplantation for Large B-cell Lymphoma with Secondary Central Nervous System Involvement

Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement

scientific article published on 19 October 2015

Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.

scientific article

Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.

scientific article

Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma

scientific article published on 29 January 2007

Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients

scientific article published on 02 October 2020

Better allele-level matching improves transplant-related mortality after double cord blood transplantation.

scientific article

Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes

scientific article published on 8 February 2017

Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM

scientific article published on 01 October 2020

CARs in chronic lymphocytic leukemia -- ready to drive

scientific article

Can we cure refractory Hodgkin's lymphoma with transplantation?

scientific article published on 07 July 2020

Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.

scientific article

Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis

scientific article

Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation ⬇️

scientific article published on June 29, 2012

Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results

scientific article published on 2 November 2016

Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.

scientific article published on 11 October 2010

Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens

scientific article published on 11 January 2019

Concise review: umbilical cord blood transplantation: past, present, and future

scientific article

Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas

scientific article published in April 2005

Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial

scientific article published on 22 March 2019

Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion.

scientific article published on September 2010

Cord-blood engraftment with ex vivo mesenchymal-cell coculture

scientific article published on December 2012

Curative potential of hematopoietic stem cell transplantation for advanced psoriasis

scientific article published on 03 April 2019

Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia

scientific article published on 30 June 2020

Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers

article

DCVax®- DIRECT: autologous activated dendritic cells for image guided intra-tumoral vaccination in patients with solid tumors - a phase I/II clinical trial in progress

scientific article published on 7 November 2013

Daratumumab-Based Maintenance in Patients with Relapsed Multiple Myeloma after Salvage Autologous Hemaptopoietic Stem Cell Transplantation

scientific article published in 2022

Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant

scientific article published on 16 July 2007

Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab

scientific article published on 18 March 2010

Differential effects of histone deacetylase inhibitors on cellular drug transporters and their implications for using epigenetic modifiers in combination chemotherapy

scientific article published on 24 August 2016

Diffuse large B-cell non-Hodgkin's lymphoma presenting as a vaginal mass in a patient with a history of intestinal mucosa-associated lymphoid tissue (MALT) lymphoma

scientific article published on 01 April 2001

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial

scientific article published on 14 October 2013

Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia

scientific article published on 01 July 2005

Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.

scientific article published on 17 June 2008

Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation

Donor cell-derived myelodysplastic syndrome with ring chromosome 7 after allogeneic hematopoietic stem cell transplant in 2 patients with lymphomas as primary disease.

scientific article published on 10 June 2014

Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center

scientific article published on 5 January 2012

Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors.

scientific article published on 12 April 2017

Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease

scientific article published on 4 August 2009

Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.

scientific article published on 20 May 2016

Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma.

scientific article published on 23 December 2015

Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review

scientific article

Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant

scientific article

Effect of non-permissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T cell depletion

scientific article published on 31 January 2018

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

scientific article

Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation

scientific article published on 16 March 2015

Epstein - Barr virus specific cytotoxic T lymphocytes for the treatment of severe epstein-barr virus mucocutaneous ulcer

scientific article published on 09 March 2020

Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.

scientific article published on 12 May 2017

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

scientific article

Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?

scientific article published in January 2006

Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results

scientific article published in March 2003

Feasibility and Reliability of Home-based Spirometry Telemonitoring in Allogeneic Hematopoietic Cell Transplant Recipients

scientific article published on 02 July 2020

Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma

scientific article published on 24 August 2011

Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma

scientific article published on 01 June 2006

Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial

scientific article published on 01 November 2018

Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant.

scientific article published on 3 January 2012

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience

scientific article

Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial.

scientific article published on 15 February 2013

Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma

scientific article

Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results

scientific article

General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation

scientific article published on 20 February 2015

Granulocyte concentrates from a single high-yield apheresis can be split to support multiple patients

scientific article published on 24 February 2014

Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

scientific article published on 13 September 2017

Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation

scientific article published on 21 October 2019

Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment

scientific article published on 30 April 2015

Hematopoietic Stem Cell Mobilization with G-CSF ⬇️

scientific article published on January 1, 2012

Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapy

scientific article

High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation

scientific article published on 21 September 2011

High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.

scientific article

High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma

scientific article published on 16 March 2013

High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies

scientific article

High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma

scientific article published on 01 July 2006

High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes

scientific article published on 22 July 2018

Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease

scientific article published on 22 August 2017

Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy

scientific article published on 10 September 2018

Hyperacute GVHD: risk factors, outcomes, and clinical implications

scientific article published on 01 April 2007

IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation

scientific article published on 20 July 2016

Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity

scientific article published on 01 April 2020

Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections

scientific article

Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis

scientific article published on 03 September 2019

Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma

scientific article published on 11 February 2019

Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes

scientific article published on 24 August 2017

Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

scientific article published on 4 January 2017

Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation

scientific article published on 09 August 2018

Impact of TKI maintenance post-allogeneic transplant in Philadelphia positive acute lymphoblastic leukemia

scientific article published on 03 June 2020

Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome

scientific article published on 26 September 2018

Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.

scientific article published on 9 April 2013

Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation

scientific article published on 27 February 2020

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies

scientific article (publication date: February 2009)

Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myeloma.

scientific article

Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma

scientific article

Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.

scientific article

Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation

scientific article

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

scientific article published on 12 September 2013

Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.

scientific article

Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

scientific article published on 9 December 2009

Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL ⬇️

scientific article published on June 25, 2012

Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies.

scientific article

Is a matched unrelated donor search needed for all allogeneic transplant candidates?

Is there an expiration date for a cord blood unit in storage?

scientific article

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

scientific article published on 01 February 2020

Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilization.

scientific article published on 23 July 2013

Lenalidomide-induced graft-vs.-Leukemia effect in a patient with chronic lymphocytic leukemia who relapsed after allogeneic stem cell transplant

scientific article

Long-Term Complete Responses to Combination Therapies and Allogeneic Stem Cell Transplants in Patients With Sézary Syndrome

scientific article published on 5 October 2014

Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.

scientific article published on July 2016

Long-term durable efficacy of autologous stem cell transplantation in POEMS syndrome

scientific article published on 21 December 2018

Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia

scientific article published on 25 July 2007

Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival

scientific article published on 14 March 2017

Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR

scientific article

Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma.

scientific article published in May 2003

Low rate of infusional toxicity after expanded cord blood transplantation.

scientific article

Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy Outcomes

scientific article

Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma

scientific article

Melphalan based autologous transplant in octogenarian multiple myeloma patients

article

Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation

scientific article published in September 2009

Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes

scientific article published on 12 September 2016

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

scientific article published in January 2018

Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial

scientific article published on 04 April 2019

Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life

scientific article

Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival

scientific article

Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation

scientific article

Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.

scientific article published on January 2009

Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.

scientific article

Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.

scientific article

Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus

scientific article published on 01 December 2004

Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical Trials

scientific article

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations

scientific article published on 17 October 2013

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial

scientific article

Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis

scientific article published on 24 December 2019

Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation.

scientific article published on December 2015

Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.

scientific article published on 2 April 2015

Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation

scientific article

Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction

scientific article

Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.

scientific article published on 17 May 2017

Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement

scientific article published on 16 January 2016

Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation

scientific article

Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant ⬇️

scientific article published on 15 July 2016

Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning.

scientific article published on 20 October 2015

Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index

scientific article published on 27 November 2015

Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure

scientific article published on 6 April 2015

Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation.

scientific article

Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years

scientific article published on 08 July 2019

Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia

scientific article published on 26 June 2019

Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia

scientific article published on 22 October 2012

Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphoma

scientific article published on 10 February 2017

Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.

scientific article published on 21 December 2017

Peripheral blood stem cell yield calculated using preapheresis absolute CD34+ cell count, peripheral blood volume processed, and donor body weight accurately predicts actual yield at multiple centers

scientific article published on 9 October 2013

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

scientific article published on 4 January 2017

Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents

scientific article published on 14 October 2016

Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma

scientific article

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

scientific article published on 02 August 2016

Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome

scientific article published on 8 November 2007

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma

scientific article

Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.

scientific article published on 7 February 2015

Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma

scientific article published on 02 March 2018

Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies

scientific article published on 07 August 2006

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation

scientific article published on 18 October 2018

Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome.

scientific article

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

scientific article

Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma

scientific article published on June 2009

Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

scientific article

Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation.

scientific article published on 28 March 2017

Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma.

scientific article published on 9 November 2016

Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma

scientific article published on 09 January 2012

Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.

scientific article published in June 2007

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.

scientific article

Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.

scientific article

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

scientific article published on 16 May 2018

Progress in novel cellular therapy options for chronic lymphocytic leukemia: the M D Anderson perspective

scientific article published on September 2014

Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study

scientific article

Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia

scientific article

Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma.

scientific article published on 6 January 2018

Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement

scientific article published on 01 September 2018

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

scientific article published on 24 July 2003

Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials

scientific article published on 23 April 2016

Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myeloma

scientific article

Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen

scientific article published on 01 May 2005

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

scientific article published on 03 July 2003

Resolved Hepatitis B Virus Infection Is Not Associated with Worse Outcome after Allogeneic Hematopoietic Stem Cell Transplantation

scientific article published on 06 January 2010

Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy

scientific article published on 12 July 2018

Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation

scientific article published on 12 July 2016

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies

scientific article published on 28 May 2007

Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma

scientific article

Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT

scientific article published on 17 March 2008

Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia

scientific article published in September 2005

Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells

scientific article

Romidepsin targets multiple survival signaling pathways in malignant T cells

scientific article

Safety, feasibility and functionality of activated autologous dendritic cells for intratumoral injection in solid tumors: a Phase I clinical trial.

scientific article published on 4 November 2015

Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma

scientific article published in March 2006

Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma

scientific article published on 15 July 2014

Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.

scientific article

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease

scientific article published in August 2005

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.

scientific article published on 31 May 2016

Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia

scientific article published on January 2011

Stem cell transplantation outcomes in lymphoblastic lymphoma

scientific article published on 27 June 2016

Stem-cell transplantation in T-cell non-Hodgkin's lymphomas

scientific article published on 05 May 2011

Steroid-Refractory Acute GVHD: Predictors and Outcomes.

scientific article published on 3 November 2011

Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation

scientific article published on 17 July 2006

Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cells

scientific article published on 16 March 2016

Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation.

scientific article

The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant Outcomes

scientific article

The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation

scientific article published on 12 January 2012

The choice of allogeneic or autologous hematopoietic transplantation for NHL.

scientific article published in January 2002

The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation

scientific article published on 26 October 2013

The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation

scientific article published on 15 January 2014

The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review.

scientific article

The role of transplantation in diffuse large B-cell lymphoma: the impact of rituximab plus chemotherapy in first-line and relapsed settings

scientific article published on March 2011

The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.

scientific article

Topical cidofovir-induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections

scientific article published on 7 December 2014

Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome

scientific article published on 29 March 2010

Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment

scientific article

Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial

scientific article

Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation

scientific article published on 05 July 2007

Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab

scientific article

Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia

scientific article published on 04 September 2015

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

scientific article

Umbilical cord blood graft engineering: challenges and opportunities.

scientific article published on June 2015

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

scientific article published on 01 February 2020

Utility of routine surveillance blood cultures in asymptomatic allogeneic hematopoietic stem cell transplant recipients with indwelling central venous catheters at a comprehensive cancer center.

scientific article published on October 2014

Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.

scientific article published on 10 June 2015

West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review

scientific article published on 18 September 2003

Paulina is supported by:

About Paulina

Help